Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
tofacitinib (xeljanz) (1 trial)
agar (1 trial)
esomeprazole (nexium) (1 trial)
lactomin (1 trial)
tj-100 (1 trial)
tj-134 (1 trial)
vonoprazan (Voquezna) (1 trial)
Arthritis (Phase 4)
Arthritis, Rheumatoid (Phase 4)
Trials (5 total)
Trial APIs (7 total)